Integra LifeSciences, a Plainsboro, N.J.-based orthopedic device company, recently launched the Integra Allograft Cancellous Sponge, a compressible bone graft composed entirely of cancellous bone, according to a company news release.
Spinal Tech
Ortho Development, a Salt Lake City-based orthopedic device company, recently released the Integrated Spine System designed to treat adult degenerative pathologies, according to a company news release.
ConforMIS has received FDA 510(k) clearance for the patient-specific iTotal CR knee replacement system, according to a company news release.
RTI Biologics, an Alachua, Fla.-based provider of orthopedic and biologic implants, reported revenues of $45.4 million for the fourth quarter of 2010, an 8 percent increase over the fourth quarter of 2009, according to a company news release.
Three bills related to eliminating healthcare reform tax on medical device manufacturers have already been introduced in Congress, and two more are expected to be introduced shortly, according to a report from The Hill.
Advertisement
In the wake of healthcare reform and a poor economy, orthopedic and spine device companies face several challenges over the next year. Here, industry experts discuss the most apparent challenges the industry stands to overcome in the future.
B. Braun has announced its Prontosan Wound Management Gel with PHMB (Polyhexanide) has received 510(k) FDA for over-the-counter use.
Stryker closed the sale of its OP-1 product family for use in orthopedic bone applications to Olympus Corp., according to a company news release.
The value of Smith & Nephew’s equity for potential buyers is $15.6 billion, based on ebitda of $1.28 billion that analysts project the company will earn this year, according to a Bloomberg Businessweek report.
SpineGuard, a San Francisco-based company that produces the PediGuard, has introduced the PediGuard Curv among key opinion leaders in spine surgery, according to a company news release.